Precision Medicine Promising for AML.
Large collections of matched genomic and clinical data could help oncologists choose the best therapies for patients with acute myeloid leukemia. New research shows that such databases can assist in determining who is most likely to benefit from risky but potentially curative stem-cell transplants.